http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100428376-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B26D7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A22C17-0006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A22C17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B26D7-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate | 2002-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100428376-B1 |
| titleOfInvention | Gene relating to anti-cancer drug resistance and use thereof |
| abstract | The present invention relates to anticancer drug resistance-related genes, proteins expressed by such genes, and uses thereof.n n n The DNA sequence of the anti-cancer drug resistance-related gene of the present invention and the amino acid sequence of the protein expressed therefrom are used in kits, DNA chips, protein chips, etc., which can diagnose the resistance of an anticancer drug to individual cancer patients and make an optimal anticancer drug prescription. It can be used as a material of, and can be used as a drug target in the development of a drug that effectively overcomes anticancer drugs or anticancer drug resistance (drug target). |
| priorityDate | 2002-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.